California is set to start selling low-cost insulin pens this January, the first such move by a state to circumvent the ...

The first CalRx product will be long-acting glargine insulin pens, the generic version of Lantus, used to regulate blood ...

A clinical trial from Wake Forest University School of Medicine shows that two widely available medications, the diabetes ...

Abbott continues to get a boost in its Medical Devices business from its Diabetes unit's portfolio of continuous glucose ...

MannKind (Nasdaq:MNKD) announced today that the FDA accepted a supplemental biologics license for its Afrezza inhaled insulin ...

Diabetes management has come a long way, and the tools we use are getting smarter. For a long time, it felt like insulin ...

Medtronic’s acquisition of Companion Medical brought a smart insulin pen, the InPen, into its diabetes care lineup.

Many people with diabetes prefer an insulin pump to insulin injections. Here's how to know if it's right for you.

The US FDA has granted a De Novo Classification for the Biolinq Shine, a novel real-time glucose sensor for people with type 2 diabetes (T2D) not on insulin.

A man with type 1 diabetes produces his own insulin after receiving genetically-modified donor islet cells, without the need ...

Automated insulin delivery was improved with improved glycemic control metrics among patients with type 2 diabetes regardless of C-peptide levels.